1. Health Canada Marketed Health Products Directorate: Complications associated with transvaginal implantation of surgical mesh for the treatment of stress urinary incontinence and pelvic organ prolapse (4 February 2010). (accessed 6 July 2011), [
http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/medeff/advisories-avis/prof/2010/surgical-mesh_nth-aah-eng.pdf
]
2. FDA Public Health Notification: Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence (October 20, 2008). (accessed 6 July 2011), [
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm061976.htm
]
3. Minassian V, Drutz H, Al-Badr A: Urinary incontinence as a worldwide problem. Int J Obstet Gynecol. 2002, 82: 327-338.
4. Wu JM, Hundley AF, Fulton RG, Myers ER: Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009, 114 (6): 1278-83. 10.1097/AOG.0b013e3181c2ce96.
5. Milsom I: Lower urinary tract symptoms in women. Curr Opin Urol. 2009, 19 (4): 337-41. 10.1097/MOU.0b013e32832b659d.